China Animal Vaccine Industry Report, 2012-2015
  • Jun./2013
  • Hard Copy
  • USD $2,500
  • Pages:128
  • Single User License
    (PDF Unprintable)       
  • USD $2,400
  • Code: HK033
  • Enterprise-wide License
    (PDF Printable & Editable)       
  • USD $3,700
  • Hard Copy + Single User License
  • USD $2,700
      
In view of the frequent occurrence of animal epidemic diseases over the years, the Chinese government has increased investment in epidemic prevention and implemented compulsory immunization system. Beginning in 2004, it has gradually included highly pathogenic avian influenza, highly pathogenic PRRS (porcine reproductive and respiratory syndrome), classical swine fever and peste des petits ruminants in the national compulsory immunization coverage following the FMD (foot-and-mouth disease), thus leading to rapid growth in animal vaccine market size.

In 2004-2012, China’s animal vaccine market size grew at a CAGR as high as 26.4%, up to approximately RMB 9.1 billion in 2012 (including net import). For years to come, the market is expected to continue to maintain a growth rate of 15% or so, to RMB 15.9 billion in 2016.

China Animal Vaccine Market Size, 2000-2012
 20130151.png

Chinese animal vaccine products include swine vaccine, poultry vaccine, cattle & sheep vaccine, pet and other vaccines. As pig and poultry breeding is the core of China’s animal husbandry, swine and poultry vaccines account for more than 85% of China’s animal vaccine market. In addition, the emerging pet industry is boosting vigorous growth in demand for pet vaccine, while there are few commercial pet vaccines from Chinese animal vaccine companies, mainly dependent on imported products with stiff prices. In future, the Chinese pet vaccine market will usher in large room for promotion.

In 2006, China carried out compulsory veterinary drug GMP certification, raised the industry access threshold, which brought a substantial decline in the number of animal vaccine enterprises, accompanied by increased industry concentration. In 2012, among domestic leading animal vaccine enterprises, China Animal Husbandry Industry Co., Ltd. made the highest animal vaccine revenue of RMB 1.17 billion, with market occupancy up to 12.9%; followed by Qingdao Yebio Bioengineering Co., Ltd (Zhejiang Shenghua Biok Biology Co., Ltd holds 38% stake), Xinjiang Tecon Animal Husbandry Bio-Technology Co., Ltd., Guangdong Dahuanong Animal Health Products Co., Ltd., Inner Mongolia Jinyu Group Stock Company, etc..

The Chinese animal vaccine market can be divided into two segments, i.e. government-procured compulsory immunization vaccines and market-oriented vaccines. Currently, there are merely five kinds of compulsory immunization vaccines, and more vaccines are market-oriented. However, in China, compulsory immunization vaccines still hold a market share of over 50%, with highly fierce competition but limited growth potential; by contrast, market-oriented vaccines will enjoy a larger space for development no matter in new product development or in animal protection improvement.

China Animal Vaccine Industry Report, 2012-2015 of ResearchInChina mainly covers the followings:
20120114.gif Market size, market structure, competition pattern, etc. of global animal vaccine industry;
20120114.gif Market size, market structure, competition pattern, import & export, etc. of China animal vaccine industry;
20120114.gif Policy environment, social environment, downstream demand, etc. of China animal vaccine industry;
20120114.gif Scale & structure prediction for China animal vaccine market and market segments;
20120114.gif Operation, animal vaccine business, forecast & outlook, etc. of 10 animal vaccine producers in China.

1. Overview of Animal Vaccine Industry
1.1 Definition
1.2 Classification
1.3 Industry Chain

2. Development Status of Animal Vaccine Industry
2.1 Status of International Animal Vaccine Industry
2.1.1 Market Size
2.1.2 Market Structure
2.1.3 Competition Pattern
2.1.4 New Diseases and New Products
2.2 Status of China Animal Vaccine Industry
2.2.1 Market Size
2.2.2 Market Structure
2.2.3 Import & Export
2.2.4 Profit Level
2.2.5 Entry Barriers
2.2.6 Competition Pattern

3. Development Environment of China Animal Vaccine Industry 
3.1 Policy Environment
3.1.1 Major Policies 
3.1.2 Compulsory Immunization Vaccine Tender System
3.2 Social Environment
3.2.1 Breeding Industry is Developing Steadily
3.2.2 Large-scale Breeding Becomes a Trend
3.2.3 Animal Epidemics Occur Frequently

4. Development Forecast of China Animal Vaccine Industry 
4.1 Overall Forecast
4.2 Swine Vaccine
4.2.1 Swine Fever Vaccine
4.2.2 FMD Vaccine
4.2.3 PRRS Vaccine
4.2.4 Porcine Circovirus Vaccine
4.3 Poultry Vaccine
4.4 Cattle & Sheep Vaccine
4.5 Pet Vaccine

5. Key Companies in China Animal Vaccine Industry 
5.1 China Animal Husbandry Industry Co., Ltd. (CAHIC)
5.1.1 Profile
5.1.2 Operation
5.1.3 Revenue Structure
5.1.4 Gross Margin
5.1.5 Animal Vaccine Business
5.1.6 Forecast & Outlook
5.2 Inner Mongolia Jinyu Group Stock Company
5.2.1 Profile
5.2.2 Operation
5.2.3 Revenue Structure
5.2.4 Gross Margin
5.2.5 R&D
5.2.6 Animal Vaccine Business
5.2.7 Forecast & Outlook
5.3 Xinjiang Tecon Animal Husbandry Bio-Technology Co., Ltd.
5.3.1 Profile
5.3.2 Operation
5.3.3 Revenue Structure
5.3.4 Gross Margin
5.3.5 R&D
5.3.6 Clients & Suppliers
5.3.7 Animal Vaccine Business
5.3.8 Forecast & Outlook
5.4 Ningbo TECH-BANK Co., Ltd.
5.4.1 Profile
5.4.2 Operation
5.4.3 Revenue Structure
5.4.4 Gross Margin
5.4.5 R&D
5.4.6 Animal Vaccine Business
5.4.7 Forecast & Outlook
5.5 Zhejiang Shenghua Biok Biology Co., Ltd.
5.5.1 Profile
5.5.2 Operation
5.5.3 Revenue Structure
5.5.4 Gross Margin
5.5.5 Clients
5.5.6 Animal Vaccine Business
5.5.7 Forecast & Outlook
5.6 Chengdu Huasun Group Inc. Ltd.
5.6.1 Profile
5.6.2 Operation
5.6.3 Revenue Structure
5.6.4 Gross Margin
5.6.5 Clients & Suppliers
5.6.6 Animal Vaccine Business
5.7 Tianjin Ringpu Bio-technology Co., Ltd.
5.7.1 Profile
5.7.2 Operation
5.7.3 Revenue Structure
5.7.4 Gross Margin
5.7.5 R&D
5.7.6 Animal Vaccine Business
5.7.7 Forecast & Outlook
5.8 Guangdong Dahuanong Animal Health Products Co., Ltd. (DHN)
5.8.1 Profile
5.8.2 Operation
5.8.3 Revenue Structure
5.8.4 Gross Margin
5.8.5 R&D
5.8.6 Animal Vaccine Business
5.8.7 Forecast & Outlook
5.9 Liaoning Yikang Biological Corporation Limited
5.9.1 Profile
5.9.2 Operation
5.9.3 Revenue Structure
5.9.4 Gross Margin
5.9.5 R&D
5.9.6 Clients & Suppliers
5.9.7 Animal Vaccine Business
5.10 Wuhan Chopper Biology Co., Ltd.
5.10.1 Profile
5.10.2 Operation
5.10.3 Revenue Structure
5.10.4 Gross Margin
5.10.5 R&D
5.10.6 Clients & Suppliers
5.10.7 Animal Vaccine Business
Animal Health Product Classification
Animal Vaccine Types (by Constituent and Property) and Features
Animal Vaccine Industry Chain
China Animal Disease Classification
Global Animal Vaccine Market Size, 2008-2016E
Basic Information of Global Animal Health Product Industry Giants 
Foreign Commercial Vaccines and Producers Over the Years
China Animal Vaccine Market Size, 2000-2012
China Animal Vaccine Product Structure by Animal Attribute, 2008-2012
China Animal Vaccine Market Structure by Sales Method
Compulsory Immunization Vaccine Product Producers in China, 2012
China Commercial Vaccine Classification and Market Situation
Import / Export Volume of Veterinary Vaccine in China, 2008-2013
Average Import / Export Price of Veterinary Vaccine in China, 2008-2013
China Veterinary Vaccine Import Countries by Import Volume, 2012
China Veterinary Vaccine Export Destination Distribution by Export Volume, 2012 
China Veterinary Vaccine Import Areas and % of Import Volume, 2012
China Veterinary Vaccine Export Areas and % of Export Volume, 2012
Gross Margin of Animal Vaccine Business of Leading Animal Vaccine Listed Companies in China, 2011-2012
Barriers to Enter China Animal Vaccine Industry
Main Products of Leading Animal Vaccine Producers in China, 2012
Revenue of Animal Vaccine Business of Major Animal Vaccine Listed Companies in China, 2011-2012
Major Gaps between Chinese Vaccine Production Technology Level and International Advanced Level
Sino-foreign Animal Vaccine Joint Ventures, 1990-2012
Major Policies on Animal Vaccine Industry in China, 2010-2013
National Animal Disease Compulsory Immunization Program in 2013
Animal Diseases with Priority to Prevention and Cure in China, 2013-2020
Defects of China’s Compulsory Immunization Tender System
Direction for China’s Compulsory Immunization Tender System Reform
Meat, Eggs and Milk Output in China, 2008-2012
Per Capita Consumption of Pork, Beef and Mutton in China, 2008-2012
China Meat Product Structure by Output, 2010-2012
Level of Large-scale Breeding in China, 2010-2020
Epidemic Prevention Costs of Pig Breeding in China, 2008-2012
Overview of Common Animal Epidemics in China
China Animal Epidemic Summary, 2013
China Animal Vaccine Market Size, 2012-2016E
China Animal Vaccine Market Structure by Animal Attribute, 2012 vs. 2016E 
Hog Breeding Stock and Slaughter in China, 2000-2012
China Swine Vaccine Market Size, 2012-2016E
Performance Comparison of Various Swine Fever Vaccines in China
China Poultry Vaccine Market Size, 2012-2016E
Newcastle Disease Vaccine Market Capacity and Ringpu Biology’s Market Share
China Cattle & Sheep Vaccine Market Size, 2012-2016E
China’s Per Capita GDP by Province/City, 2012
China Pet Vaccine Market Size, 2012-2016E
China Pet Vaccine Market Supply Companies 
Revenue and Net Income of CAHIC, 2008-2012
Revenue Breakdown of CAHIC by Product, 2010-2012
Revenue Structure of CAHIC by Product, 2010-2012
Revenue Breakdown of CAHIC by Region, 2010-2012
Revenue Structure of CAHIC by Region, 2010-2012
Gross Margin of Main Products of CAHIC, 2010-2012
Animal Vaccine Capacity Layout of CAHIC
Animal Vaccine Projects under Construction of CAHIC, 2013
Revenue and Net Income of CAHIC, 2011-2015E
Revenue and Net Income of Jinyu Group, 2008-2012
Revenue Breakdown of Jinyu Group by Product, 2010-2012
Revenue Structure of Jinyu Group by Product, 2010-2012
Revenue Breakdown of Jinyu Group by Region, 2010-2012
Revenue Structure of Jinyu Group by Region, 2010-2012
Gross Margin of Main Business of Jinyu Group, 2010-2012
R&D Costs and % of Total Revenue of Jinyu Group, 2010-2012
Animal Vaccine-related Subsidiaries of Jinyu Group, 2012
Revenue and Net Income of Jinyu Group, 2011-2015E
Revenue and Net Income of Tecon, 2008-2012
Revenue Breakdown of Tecon by Product, 2010-2012
Revenue Structure of Tecon by Product, 2010-2012
Revenue Breakdown of Tecon by Region, 2010-2012
Revenue Structure of Tecon by Region, 2010-2012
Gross Margin of Main Products of Tecon, 2010-2012
R&D Costs and % of Total Revenue of Tecon, 2010-2012
Tecon’s Revenue from Top 5 Clients and % of Total Revenue, 2010-2012
Name List and Revenue Contribution of Tecon’s Top 5 Clients, 2012
Tecon’s Procurement from Top 5 Suppliers and % of Total Procurement, 2012
Progress of Animal Vaccine R&D Projects of Tecon, 2012
Revenue and Net Income of Tecon, 2011-2015E
Revenue and Net Income of TECH-BANK, 2008-2012
Revenue Breakdown of TECH-BANK by Product, 2010-2012
Revenue Structure of TECH-BANK by Product, 2010-2012
Revenue Breakdown of TECH-BANK by Region, 2010-2012
Revenue Structure of TECH-BANK by Region, 2010-2012
Gross Margin of Main Products of TECH-BANK, 2010-2012
R&D Costs and % of Total Revenue of TECH-BANK, 2010-2012
Revenue and Net Income of Chengdu TECBOND Biological Products, 2010-2012
Revenue and Net Income of TECH-BANK, 2011-2015E
Revenue and Net Income of Shenghua Biok, 2008-2012
Revenue Breakdown of Shenghua Biok by Product, 2010-2012
Revenue Structure of Shenghua Biok by Product, 2010-2012
Revenue Breakdown of Shenghua Biok by Region, 2010-2012
Revenue Structure of Shenghua Biok by Region, 2010-2012
Gross Margin of Main Products of Shenghua Biok, 2010-2012
Shenghua Biok’s Revenue from Top 5 Clients and % of Total Revenue, 2010-2012
Name List and Revenue Contribution of Shenghua Biok’s Top 5 Clients, 2012
Revenue and Net Income of Qingdao Yebio Bioengineering, 2008-2012
Revenue and Net Income of Shenghua Biok, 2011-2015E
Revenue and Net Income of Huasun Group, 2008-2012
Revenue Breakdown of Huasun Group by Product, 2010-2012
Revenue Structure of Huasun Group by Product, 2010-2012
Revenue Breakdown of Huasun Group by Region, 2010-2012
Revenue Structure of Huasun Group by Region, 2010-2012
Gross Margin of Main Products of Huasun Group, 2010-2012
Huasun Group’s Revenue from Top 5 Clients and % of Total Revenue, 2010-2012
Name List and Revenue Contribution of Huasun Group’s Top 5 Clients, 2012
Huasun Group’s Procurement from Top 5 Suppliers and % of Total Procurement, 2010-2012
Name List and Procurement Contribution of Huasun Group’s Top 5 Suppliers, 2012
Revenue and Net Income of Ringpu Bio-technology, 2008-2012
Revenue Breakdown of Ringpu Bio-technology by Product, 2010-2012
Revenue Structure of Ringpu Bio-technology by Product, 2010-2012
Revenue Breakdown of Ringpu Bio-technology by Region, 2010-2012
Revenue Structure of Ringpu Bio-technology by Region, 2010-2012
Gross Margin of Main Products of Ringpu Bio-technology, 2010-2012
R&D Costs and % of Total Revenue of Ringpu Bio-technology, 2008-2012
Output and Sales Volume of Animal Vaccine Products of Ringpu Bio-technology, 2011-2012
Sales and Gross Margin of Animal Vaccine of Ringpu Bio-technology by Product, 2012 
Animal Vaccine Business-related Subsidiaries of Ringpu Bio-technology, 2012
Revenue and Net Income of Animal Vaccine Business-related Subsidiaries of Ringpu Bio-technology, 2012
Progress of Animal Vaccine-related Projects of Ringpu Bio-technology, 2012
Revenue and Net Income of Ringpu Bio-technology, 2011-2015E
Revenue and Net Income of Dahuanong, 2008-2012
Revenue Breakdown of Dahuanong by Product, 2010-2012
Revenue Structure of Dahuanong by Product, 2010-2012
Revenue Breakdown of Dahuanong by Region, 2010-2012
Revenue Structure of Dahuanong by Region, 2010-2012
Gross Margin of Main Products of Dahuanong, 2010-2012
R&D Costs and % of Total Revenue of Dahuanong, 2010-2012
Output, Sales Volume and Sales-Output Ratio of Veterinary Biological Products of Dahuanong, 2011-2012
Progress of Animal Vaccine-related Projects of Dahuanong by end-2012
Revenue and Net Income of Dahuanong, 2011-2015E
Revenue and Net Income of Yikang Biological, 2009-2011
Revenue Breakdown of Yikang Biological by Product, 2009-2011
Revenue Structure of Yikang Biological by Product, 2009-2011
Revenue Breakdown of Yikang Biological by Region, 2009-2011
Revenue Structure of Yikang Biological by Region, 2009-2011
Gross Margin of Main Products of Yikang Biological, 2009-2011 
R&D Costs and % of Total Revenue of Yikang Biological, 2009-2011
Yikang Biological’s Revenue from Top 5 Clients and % of Total Revenue, 2009-2011
Name List and Revenue Contribution of Yikang Biological’s Top 5 Clients, 2011
Yikang Biological’s Procurement from Top 5 Suppliers and % of Total Procurement, 2009-2011
Name List and Procurement Contribution of Yikang Biological’s Suppliers, 2011
Animal Vaccine Production Lines of Yikang Biological, 2009-2011
Capacity, Output and Capacity Utilization of Yikang Biological, 2009-2011
Output, Sales Volume and Sales-Output Ratio of Yikang Biological, 2009-2011
Average Sales Price of Main Products of Yikang Biological, 2009-2011
Revenue Structure of Yikang Biological by Sales Model, 2009-2011
Revenue and Net Income of Chopper Biology, 2009-2011
Revenue Breakdown of Chopper Biology by Product, 2009-2011
Revenue Structure of Chopper Biology by Product, 2009-2011
Revenue Breakdown of Chopper Biology by Region, 2009-2011
Revenue Structure of Chopper Biology by Region, 2009-2011
Gross Margin of Main Products of Chopper Biology, 2009-2011
R&D Costs and % of Total Revenue of Chopper Biology, 2009-2011
Chopper Biology’s Revenue from Top 5 Clients and % of Total Revenue, 2009-2011
Name List and Revenue Contribution of Chopper Biology’s Top 5 Clients, 2011
Sales Contract between Chopper Biology and Animal Husbandry and Veterinary Bureau of Hubei Province, 2011
Chopper Biology’s Procurement from Top 5 Suppliers and % of Total Procurement, 2009-2011
Name List and Procurement Contribution of Chopper Biology’s Suppliers, 2011
Sales of Major Vaccine Products of Chopper Biology, 2009-2011
Vaccine Capacity, Output and Capacity Utilization of Chopper Biology, 2009-2011
Vaccine Output, Sales Volume and Sales-Output Ratio of Chopper Biology, 2009-2011
Average Sales Price of Major Vaccine Products of Chopper Biology, 2009-2011
Investment Plan of Chopper Biology, 2012 

China Independent Clinical Laboratory Industry Report, 2019-2025

China's independent clinical laboratory industry is still in its infancy. In 2018, it only saw the penetration rate of about 5%, far below 40% or more in Europe, the United States and Japan. The main ...

Global and China Monoclonal Antibody Industry Report, 2019-2025

Global monoclonal antibody market can be presented as follows: 1. Monoclonal antibody drug market booms and is highly concentrated with the approvals for such drugs.Monoclonal antibody drugs have bee...

China Contract Research Organization (CRO) Industry Report, 2019-2025

The steadily growing global pharmaceutical industry where more and more new drugs have been approved, and the soaring spending on drug research and development in recent years, are a boon for global c...

China Blood Product Industry Report, 2019-2025

With the adjustment of the national medical insurance catalogue, the clinical application and reimbursement rate of almost all blood products have been greatly improved, and the market for blood produ...

China Human Vaccine Industry Report, 2018-2022

As the world’s largest producer of human vaccines, China has established a full-life-cycleregulatory system covering vaccine R&D, production, distribution, and vaccination. The lot release volum...

China Contract Research Organization(CRO) Industry Report, 2017-2021

Under the pressure from higher R&D costs, longer R&D cycle and lower R&D success rate in pharmaceutical industry worldwide, over 50 percent of pharmaceutical enterprises have had the devel...

China Vacuum Blood Collection Device Industry Report, 2017-2021

China’s vacuum blood collection device industry now flourishes after start-up and growth stages. Along with steady improvement in economic environment, rising per-capita disposable income, greater awa...

China Independent Clinical Laboratory Industry Report, 2017-2021

China's independent clinical laboratory industry started late, and is still in its infancy. In 2016, it only saw the penetration rate of about 4%, far below 40% or more in Europe, the United States an...

China Human Vaccine Industry Report, 2017-2021

The human vaccine industry presented the following main characteristics in 2016 in China: 1. Lot release volume of human vaccines declined.Affected by the illegal vaccine case in Mar 2016 in Shandong...

China Independent Clinical Laboratory Industry Report, 2016-2020

Owing to a large population base, uneven distribution of medical resources among regions, aging population, and continuous advance of health care reform, the Chinese independent clinical laboratory ma...

China Human Vaccine Industry Report, 2016-2020

Amid the unsafe domestic vaccine events, China’s human vaccine lot release volume in 2015 fell by 17.9% year on year to only 650 million doses,touching a 5-year low. Moreover, with the improvements in...

China Animal Vaccine Industry Report, 2016-2020

Animal vaccine is a kind of biological agent that enables inoculated animals to produce active immunity for disease prevention. In recent years, European and American animal vaccine markets have seen ...

China Blood Product Industry Report, 2016-2019

Recombinant blood products have developed for many years in foreign countries, but China’s blood products are still proteins extracted from human blood. Thus, reserves and control of plasma resources ...

China Contract Research Organization (CRO) Industry Report, 2015-2018

In recent years, China's contract research organization (CRO) industry has developed rapidly, with the market size rising from RMB8.5 billion in 2007 to RMB42.6 billion in 2014, registering a CAGR of ...

Global and China Industrial Enzyme Industry Report, 2014-2017

In recent years, the global industrial enzyme preparation market size increased year by year, registering a CAGR of 5%, approximating USD4.2178 billion in 2014. At present, the global industrial enzym...

China Blood Product Industry Report, 2015-2018

Recombinant blood products have developed for many years in foreign countries, but China’s blood products are still proteins extracted from human blood. Thus, reserves and control of plasma resources ...

China Human Vaccine Industry Report, 2015-2018

A vaccine is a preventive biological product for human use that prevents and controls the occurrence and prevalence of infectious diseases, so the demand for such products is relatively rigid. Due to ...

China Vacuum Blood Collection Industry Report, 2014-2017

The vacuum blood collection system consisting of vacuum blood collection tubes, disposable blood collection needles, tourniquets, etc transfers human venous blood to closed containers and makes it int...

2005-2014 www.researchinchina.com All Rights Reserved 京ICP备05069564号-1 京公网安备1101054484号
在线客服系统